{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:07:10Z","timestamp":1780466830262,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjcard.2026.04.030","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:55:45Z","timestamp":1776696945000},"page":"187-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future Directions"],"prefix":"10.1016","volume":"270","author":[{"given":"Kristen B.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagmeet P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P.","family":"Zeitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.04.030_bib0001","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","article-title":"The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Camm","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the Diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0003","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0006","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0007","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0009","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/europace\/euaa426","article-title":"Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future","volume":"23","author":"Heijman","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023838","article-title":"AIM-AF: a physician survey in the United States and Europe","volume":"11","author":"Camm","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0011","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamacardio.2019.4513","article-title":"Association between obesity-mediated atrial fibrillation and therapy with sodium channel blocker antiarrhythmic drugs","volume":"5","author":"Ornelas-Loredo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0014","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5664\/jcsm.3696","article-title":"Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation","volume":"10","author":"Goyal","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/FJC.0000000000000280","article-title":"The role of pharmacogenetics in atrial fibrillation therapeutics: is personalized therapy in sight?","volume":"67","author":"Darbar","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025293","article-title":"Educational needs of people living with atrial fibrillation: a qualitative study","volume":"11","author":"Ferguson","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.007958","article-title":"Shared decision making in cardiac electrophysiology procedures and arrhythmia management","volume":"14","author":"Chung","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0018","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.cjco.2021.09.004","article-title":"Racial and ethnic differences in the management of atrial fibrillation","volume":"3","author":"Tamirisa","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0019","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9149(98)00006-X","article-title":"Mortality in the survival with ORal D-sotalol (SWORD) trial: why did patients die?","volume":"81","author":"Pratt","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0021","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007716","article-title":"Initial precipitants and recurrence of atrial fibrillation","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0023","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","article-title":"Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery","volume":"51","author":"Echahidi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007437","article-title":"Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis","volume":"13","author":"AlTurki","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0025","first-page":"744","article-title":"Postoperative atrial fibrillation following coronary artery bypass graft surgery predicts long-term atrial fibrillation and stroke","volume":"18","author":"Konstantino","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0026","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2013.12.010","article-title":"New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft","volume":"167","author":"Lee","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0027","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/SLA.0000000000001626","article-title":"Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE trial","volume":"264","author":"Cardinale","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0028","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/bjs.10548","article-title":"Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer","volume":"104","author":"Ojima","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0029","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/eurheartj\/ehs423","article-title":"Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Ozaydin","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.athoracsur.2009.04.074","article-title":"A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection","volume":"88","author":"Tisdale","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0031","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ahj.2003.10.041","volume":"147","author":"Auer","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131930","article-title":"Recurrence of new-onset post-operative AF after cardiac surgery: detected by implantable loop recorders: a systematic review and meta-analysis","volume":"404","author":"Kaur","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0033","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0034","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2017.08.004","article-title":"Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry","volume":"152","author":"Esato","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0035","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.hrthm.2016.03.003","article-title":"Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications","volume":"13","author":"Siontis","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0036","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0037","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-13-1272","article-title":"Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation","volume":"78","author":"Senoo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0038","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0039","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacep.2024.08.010","article-title":"Atrial fibrillation burden on a 14-day ECG monitor: findings from the GUARD-AF Trial screening arm","volume":"11","author":"Singer","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0041","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \u201cpill-in-the-pocket\u201d approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0042","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0043","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.jacc.2019.09.050","article-title":"Natural history of subclinical atrial fibrillation detected by implanted loop recorders","volume":"74","author":"Diederichsen","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0044","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jacep.2024.11.020","article-title":"Arrhythmia recurrence and rhythm control strategies after catheter ablation of newly diagnosed atrial fibrillation (ARRC-AF study)","volume":"11","author":"Saksena","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0045","article-title":"Efficacy of short-term antiarrhythmic drugs use after catheter ablation of atrial fibrillation-a systematic review with meta-analyses and trial sequential analyses of randomized controlled trials","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0046","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/eurheartj\/ehx666","article-title":"PulmOnary vein isolation with vs. without continued antiarrhythmic drug trEatment in subjects with recurrent atrial fibrillation (POWDER AF): results from a multicentre randomized trial","volume":"39","author":"Duytschaever","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0047","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0048","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0049","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamacardio.2024.0675","article-title":"Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis","volume":"9","author":"Oraii","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/CRD.0b013e3181f4a6a2","article-title":"Vernakalant: a new drug to treat patients with acute onset atrial fibrillation","volume":"19","author":"Tian","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0051","doi-asserted-by":"crossref","DOI":"10.1113\/JP287124","article-title":"Prospective in silico trials identify combined SK and K(2)P channel block as an effective strategy for atrial fibrillation cardioversion","author":"Dasi","year":"2024","journal-title":"J Physiol"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0052","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cjco.2024.10.008","article-title":"Effectiveness of anti-inflammatory agents to prevent atrial fibrillation after cardiac surgery: a systematic review and network meta-analysis","volume":"7","author":"Malektojari","year":"2025","journal-title":"CJC Open"},{"key":"10.1016\/j.amjcard.2026.04.030_bib0053","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2021.08.013","article-title":"Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease","volume":"243","author":"Burnham","year":"2022","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:30:32Z","timestamp":1780403432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"alternative-id":["S0002914926002602"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future Directions","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}